I. Synthesis of Myocardial Imaging Agents for Diagnosis of MCAD Deficiency. II. Synthesis of [fluorine-18] Fluoroaryl Estrogens as Receptor Based Tumor Imaging Agents for Breast Cancer

The synthesis of a (fluorine-18) fluoroaryl estrogen in no-carrier-added form requires the use of ($\sp{18}$F) F$\sp-$. A great amount of effort has been made toward incorporation of ($\sp{18}$F) F$\sp-$onto an electron-rich aromatic ring, but none have found general application. Several strategies were explored for the synthesis of a (fluorine-18) fluoroaryl estrogen. The synthesis of 2- ($\sp{18}$F) fluoroestradiol (12) required the use of a trimethylammonium salt as a leaving group and a ketone as an activating group. Incorporation yields of fluorine-18 were low, between 10 and 20%, but reproducible. This allowed the testing of 2-($\sp{18}$F) fluoroestradiol in immature female rats. The only information that could be reliably taken from this study was that uptake of 12 was receptor mediated. In order to more accurately assess the ability of 12 to localize selectively in target tissue and resist metabolism, it must be administered to animals possessing SHBG.

Name thesis:degree_name

Ph.D.

Level thesis:degree_level

Dissertation

Discipline thesis:degree_discipline

Chemistry

Grantor

University of Illinois at Urbana-Champaign

Year dc:date

2015

Author dc:creator

• Hostetler, Eric Dale

Contributors dc:contributor

• Katzenellenbogen, John A.

• Health Sciences, Radiology

Language dc:language

eng

Identifier

(MiAaPQ)AAI9904481

OAI identifier oai:identifier

oai:www.ideals.illinois.edu:2142/84411